iHuman (IH)
NYSE:IH
US Market

iHuman (IH) Financial Statements

73 Followers

iHuman Financial Overview

iHuman's market cap is currently ―. The company's EPS TTM is $0.381; its P/E ratio is 4.31; iHuman is scheduled to report earnings on September 19, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-¥ 251.53M¥ 230.61M¥ 242.68M¥ 237.82M
Gross Profit-¥ 177.10M¥ 163.19M¥ 169.88M¥ 164.91M
EBIT-¥ 38.54M¥ 22.61M¥ 11.29M¥ -10.57M
EBITDA-¥ 38.54M¥ 22.61M¥ 11.29M¥ -10.57M
Net Income Common Stockholders-¥ 39.48M¥ 21.79M¥ 13.12M¥ -7.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 152.24M¥ 949.60M¥ 856.33M¥ 794.09M¥ 855.36M
Total Assets¥ 191.99M¥ 1.22B¥ 1.13B¥ 1.09B¥ 1.10B
Total Debt¥ 1.31M¥ 13.69M¥ 18.10M¥ 28.42M¥ 34.25M
Net Debt¥ -150.93M¥ -935.92M¥ -838.24M¥ -765.66M¥ -821.12M
Total Liabilities¥ 81.77M¥ 485.30M¥ 460.77M¥ 475.74M¥ 492.51M
Stockholders Equity¥ 111.56M¥ 739.39M¥ 668.59M¥ 618.42M¥ 608.37M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CNY

iHuman Earnings and Revenue History

iHuman Debt to Assets

iHuman Cash Flow

iHuman Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis